Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis

Published:2015-09-23 Issue:1081 Volume:91 Page:627-633
ISSN:0032-5473
Container-title:Postgraduate Medical Journal
language:en
Short-container-title:Postgrad Med J

Author:

Yun Seongseok,Vincelette Nicole D,Abraham Ivo

Publisher

BMJ

Subject

General Medicine

Reference40 articles.

1. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol Rev,2004

2. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials;Swain;Cancer,2003

3. Cardiac toxicity 4 to 20 years after completing anthracycline therapy;Steinherz;JAMA,1991

4. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer;Pinder;J Clin Oncol,2007

5. Identification of the molecular basis of doxorubicin-induced cardiotoxicity;Zhang;Nat Med,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guideline-directed medical therapy in chemotherapy-induced cardiotoxicity and heart failure: current perspectives and practices;Cardiology Plus;2024-03-07

2. Protective effects of sacubitril/valsartan in anthracyclines-induced cardiotoxicity: A Systematic Review and Meta-Analysis;2023-08-17

3. Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials;Reviews on Recent Clinical Trials;2023-05

4. Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis;Frontiers in Cardiovascular Medicine;2022-08-11

5. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study;Acta Oncologica;2022-07-26